Browse by Journal Title

2023

Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study.
Pham, T.T., Nimptsch, K., Papadimitriou, N., Aleksandrova, K., Jenab, M., Gunter, M.J., Le Marchand, L., Li, L., Lynch, B.M., Castellví-Bel, S., Phipps, A.I., Schmit, S.L., Brenner, H., Ogino, S., Giovannucci, E. and Pischon, T.
Journal of Cancer Research and Clinical Oncology 149 (16): 14889-14900. November 2023

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.
Kidess, E., Giesecke, Y., Eichhorn, I., Mohr, R., Jann, H., Fischer, C., Wiedenmann, B., Roderburg, C., Tacke, F. and Sigal, M.
Journal of Cancer Research and Clinical Oncology 149 (12): 10925-10933. September 2023

Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma.
Scheer, M., Hallmen, E., Vokuhl, C., Fuchs, J., Tunn, P.U., Münter, M., Timmermann, B., Bauer, S., Henssen, A.G., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Eggert, A., Klingebiel, T. and Koscielniak, E.
Journal of Cancer Research and Clinical Oncology 149 (5): 1717-1731. May 2023

Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Kleo, K., Jovanovic, V.M., Arndold, A., Lehmann, A., Lammert, H., Berg, E., Harloff, H., Treese, C., Hummel, M. and Daum, S.
Journal of Cancer Research and Clinical Oncology 149 (3): 1049-1061. March 2023

2021

The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents.
Scheer, M., Vokuhl, C., Bauer, S., Fuchs, J., Loff, S., Timmermann, B., Münter, M., Henssen, A.G., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Koscielniak, E. and Klingebiel, T.
Journal of Cancer Research and Clinical Oncology 147 (12): 3735-3747. December 2021

2020

Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Scheer, M., Blank, B., Bauer, S., Vokuhl, C., Stegmaier, S., Feuchtgruber, S., Henssen, A., Sparber-Sauer, M., Eggert, A., Handgretinger, R., Pekrun, A., Rossig, C., Rutkowski, S., Schlegel, P.G., Schrappe, M., Simon, T., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Jahnukainen, K., Fuchs, J., Bielack, S.S., Koscielniak, E. and Klingebiel, T.
Journal of Cancer Research and Clinical Oncology 146 (4): 953-960. April 2020

2018

Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.
Kratzsch, T., Kuhn, S.A., Joedicke, A., Hanisch, U.K., Vajkoczy, P., Hoffmann, J. and Fichtner, I.
Journal of Cancer Research and Clinical Oncology 144 (5): 809-819. May 2018

2015

Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
Laster, B.H., Isaacson, C., Perets, E., Msamra, M., Priel, E., Kalef-Ezra, J. and Kost, J.
Journal of Cancer Research and Clinical Oncology 141 (1): 23-34. January 2015

2014

Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.
Mensen, A., Na, I.K., Häfer, R., Meerbach, A., Schlecht, M., Pietschmann, M.L. and Gruhn, B.
Journal of Cancer Research and Clinical Oncology 140 (11): 1971-1980. November 2014

2009

Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort.
Seidel, D., Becker, N., Rohrmann, S., Nimptsch, K. and Linseisen, J.
Journal of Cancer Research and Clinical Oncology 135 (4): 533-541. April 2009

2006

Arnold Graffi (1910-2006) : A pioneer of experimental cancer research.
Wunderlich, V. and Bielka, H.
Journal of Cancer Research and Clinical Oncology 132 (8): 483-485. August 2006

2005

Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.
Pietschmann, A., Mehdipour, P., Mehdipour, P., Atri, M., Hofmann, W., Hosseini-Asl, S., Scherneck, S., Mundlos, S. and Peters, H.
Journal of Cancer Research and Clinical Oncology 131 (8): 552-558. 1 January 2005

2003

Analysis of DLC-1 expression in human breast cancer.
Plaumann, M., Seitz, S., Frege, R., Estevez-Schwarz, L. and Scherneck, S.
Journal of Cancer Research and Clinical Oncology 129 (6): 349-354. June 2003

2002

Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Oertel, J., Kingreen, D., Busemann, C., Stein, H. and Doerken, B.
Journal of Cancer Research and Clinical Oncology 128 (4): 182-188. April 2002

2001

Identification of a recurrent BRCA1 mutation in German breast-cancer and/or ovarian-cancer families.
Hofmann, W., Jandrig, B., Classen, E., Nestle-Kraemling, C., Chang-Claude, J. and Scherneck, S.
Journal of Cancer Research and Clinical Oncology 127 (3): 200-202. 1 January 2001

2000

BRCA1 and BRCA2 - breast cancer susceptibility genes.
Hofmann, W. and Schlag, P.M.
Journal of Cancer Research and Clinical Oncology 126 (9): 487-496. 1 September 2000

Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5' -> 5')-N4-octadecyl-1-beta-d-arabinofuranosylcytosine.
Horber, D.H., Cattaneo-Pangrazzi, R.M.C., von Ballmoos, P., Schott, H., Ludwig, P.S., Eriksson, S., Fichtner, I. and Schwendener, R.A.
Journal of Cancer Research and Clinical Oncology 126 (6): 311-319. 1 January 2000

1997

High-mobility-group proteins and cancer - an emerging link.
Wunderlich, V. and Boettger, M.
Journal of Cancer Research and Clinical Oncology 123 (3): 133-140. March 1997

BRCA1 mutations and phenotype.
Grade, K., Hoeffken, K., Kath, R., Nothnagel, A., Bender, E. and Scherneck, S.
Journal of Cancer Research and Clinical Oncology 123 : 69-70. 1 January 1997

1996

BRCA1 mutation update and analysis.
Grade, K., Jandrig, B. and Scherneck, S.
Journal of Cancer Research and Clinical Oncology 122 : 702-706. 1 January 1996

Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.
Naundorf, H., Parczyk, K., Zschiesche, W., Reinecke, S., Buettner, B., Saul, G.J., Sinn, B. and Fichtner, I.
Journal of Cancer Research and Clinical Oncology 122 : 14-20. 1 January 1996

Vincristine induction of mutant and wild-type human multidrug-resitance promoters is cell- type-specific and dose-dependent.
Stein, U., Walther, W. and Shoemaker, R.H.
Journal of Cancer Research and Clinical Oncology 122 : 275-282. 1 January 1996

1995

Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor alpha by U 937 cells.
Eue, I., Zeisig, R. and Arndt, D.
Journal of Cancer Research and Clinical Oncology 121 : 350-356. 1 January 1995

Biotherapy of cancer. Perspectives of immunotherapy and genetherapy.
Schirrmacher, V., Hagmueller, E., Lehnert, T., Pomer, S., Ahlert, T., Ockert, D. and Schlag, P.M.
Journal of Cancer Research and Clinical Oncology 121 : 443-451. 1 January 1995

Prognostic value of proliferating cell nuclear antigenand c-erbB-2 compared with conventional histopathological factors in breast cancer.
Schoenborn, I., Zschiesche, W., Minguillon, C., Spitzer, E., Moehner, M., Ebeling, K. and Grosse, R.
Journal of Cancer Research and Clinical Oncology 121 : 115-122. 1 January 1995

Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro.
Zeisig, R., Rudolph, M., Eue, I. and Arndt, D.
Journal of Cancer Research and Clinical Oncology 121 : 69-75. 1 January 1995

1994

Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.
Walther, W. and Stein, U.
Journal of Cancer Research and Clinical Oncology 120 : 471-478. 1 January 1994

Flow-cytometrically monitored chromatin in situ testing in the breast cell line H184A1N4.
Weibeta, H., Langen, P., Nitschke, U. and Thun, I.
Journal of Cancer Research and Clinical Oncology 120 : 399-402. 1 January 1994

1993

Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice.
Naundorf, H., Fichtner, I., Saul, G.J., Haensch, W. and Buettner, B.
Journal of Cancer Research and Clinical Oncology 119 : 652-656. 1 January 1993

1992

Membrane transport in multidrug resistance, development, and disease. AACR Special Conference in Cancer Research.
Jandrig, B. and Wunderlich, V.
Journal of Cancer Research and Clinical Oncology 118 (3): 238-239. March 1992

Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea- induced rat mammary tumors. 2. Influence on estrogen receptor.
Goerlich, M., Winterfeld, G., Hauff, P., Arnold, W., Fichtner, I. and Staab, H.J.
Journal of Cancer Research and Clinical Oncology 119 : 97-100. 1 January 1992

Establishment and characterization of a new human oestradiol- and progesteron-receptor-positive mammary carcinoma serially transplantable in nude mice.
Naundorf, H., Fichtner, I., Buettner, B. and Frege, J.
Journal of Cancer Research and Clinical Oncology 119 : 35-40. 1 January 1992

Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumors. 1. Influence on tumor growth.
Winterfeld, G., Hauff, P., Goerlich, M., Arnold, W., Fichtner, I. and Staab, H.J.
Journal of Cancer Research and Clinical Oncology 119 : 91-96. 1 January 1992

1991

Ribonucleotide reductase in melanoma tissue. EPR detection in human amelanotic melanoma and quenching of the tyrosine radical by 4-hydroxyanisole.
Lassmann, G., Liermann, B., Arnold, W. and Schwabe, K.
Journal of Cancer Research and Clinical Oncology 117 : 91-95. 1 January 1991